CSBR
CHAMPIONS ONCOLOGY, INC.
Key Financials
Revenue
$59.4M
↑ 4.4%
Operating Income
$-1140000
↓ 125.0%
Net Income
$-1175000
↓ 125.0%
Total Liabilities
$22.9M
↓ 19.8%
Total Assets
$27.0M
↓ 16.6%
EPS (Diluted)
$-0.08
↓ 124.2%
Shareholders' Equity
$3.9M
↑ 4.4%
Cash & Equivalents
$3.2M
↑ 278.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 9/11/2026 | View on SEC |
| 8-K | 9/10/2026 | View on SEC |
| DEFA14A | 8/28/2026 | View on SEC |
| DEF 14A | 8/28/2026 | View on SEC |
| 10-K | 7/27/2026 | View on SEC |
| 8-K | 7/27/2026 | View on SEC |
| 8-K | 3/30/2026 | View on SEC |
| 10-Q | 3/12/2026 | View on SEC |
| 8-K | 3/12/2026 | View on SEC |
| 4 | 1/30/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CSBR |
| Company Name | CHAMPIONS ONCOLOGY, INC. |
| CIK | 771856 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 0430 |
| State of Incorporation | DE |
| Phone | 410-369-0365 |